| Code | Description | Claims | Beneficiaries | Total Paid |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
12,830 |
11,996 |
$344K |
| 99233 |
Prolong inpt eval add15 m |
12,032 |
4,400 |
$244K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,051 |
11,528 |
$187K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
35,303 |
30,695 |
$176K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
2,054 |
1,598 |
$81K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,936 |
7,387 |
$72K |
| 93000 |
|
13,734 |
13,328 |
$55K |
| 99223 |
Prolong inpt eval add15 m |
1,035 |
936 |
$39K |
| 99222 |
Initial hospital care, per day, moderate complexity |
784 |
711 |
$32K |
| 93880 |
|
1,363 |
1,104 |
$22K |
| 93015 |
|
1,500 |
1,490 |
$19K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
974 |
974 |
$18K |
| 93970 |
|
714 |
584 |
$13K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
483 |
479 |
$12K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
726 |
725 |
$6K |
| 93458 |
|
52 |
52 |
$5K |
| 99215 |
Prolong outpt/office vis |
169 |
150 |
$4K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
239 |
129 |
$4K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
149 |
67 |
$4K |
| J2785 |
Injection, regadenoson, 0.1 mg |
78 |
77 |
$3K |
| 93294 |
|
274 |
274 |
$3K |
| 93297 |
|
480 |
479 |
$2K |
| 93017 |
|
259 |
258 |
$2K |
| 99152 |
|
309 |
288 |
$2K |
| 93018 |
|
348 |
347 |
$1K |
| 93016 |
|
199 |
198 |
$911.21 |
| 93280 |
|
52 |
50 |
$864.71 |
| 93224 |
|
66 |
66 |
$675.26 |
| 76937 |
|
260 |
253 |
$625.31 |
| 99407 |
|
228 |
224 |
$373.55 |
| 3008F |
|
1,831 |
1,779 |
$366.78 |
| 93248 |
|
92 |
91 |
$334.28 |
| 99406 |
|
366 |
363 |
$250.78 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,043 |
978 |
$215.21 |
| J7050 |
Infusion, normal saline solution, 250 cc |
405 |
403 |
$192.97 |
| 1159F |
|
2,564 |
2,468 |
$164.97 |
| 3074F |
|
214 |
214 |
$161.60 |
| 93925 |
|
61 |
53 |
$122.62 |
| 93246 |
|
60 |
59 |
$106.28 |
| 1160F |
|
2,489 |
2,394 |
$74.26 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
12 |
12 |
$47.70 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
185 |
184 |
$0.00 |
| 1036F |
|
327 |
321 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
312 |
307 |
$0.00 |
| 4086F |
|
106 |
106 |
$0.00 |
| G8967 |
Fda approved oral anticoagulant is prescribed |
34 |
33 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
32 |
32 |
$0.00 |
| 1123F |
|
25 |
25 |
$0.00 |
| 3079F |
|
28 |
28 |
$0.00 |
| 1124F |
|
117 |
117 |
$0.00 |
| 3078F |
|
299 |
298 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
319 |
310 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
40 |
40 |
$0.00 |
| 3077F |
|
38 |
37 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
111 |
109 |
$0.00 |
| 4040F |
|
213 |
212 |
$0.00 |
| G8598 |
Aspirin or another antiplatelet therapy used |
107 |
107 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
293 |
288 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
51 |
51 |
$0.00 |
| G9724 |
Patients who had documentation of use of anticoagulant medications overlapping the measurement year |
14 |
14 |
$0.00 |